Lidocaine 10% Spray Reduces Pain During Intrauterine Device Insertion

Not Applicable

Completed

• Conditions: Pain
• Interventions: Drug: Placebo; Drug: Lidocaine Spray

• Registration Number: NCT02020551
• Lead Sponsor: Kayseri Education and Research Hospital

Brief Summary

Pain during intrauterine device (IUD) insertion can be a barrier to initiation. Misoprostol and nonsteroidal drugs have found to be ineffective by clinical trials.Investigators tested whether intracervical 2% lidocaine gel decreased insertion pain compared to placebo.

Detailed Description

Not available

Study Timeline

• Study Start: 2013-05
• Primary Completion: 2013-08
• Status Verified: 2013-12
• Study First Submitted: 2013-12-11
• Study First Submitted QC: 2013-12-24
• Last Update Submitted: 2013-12-24
• Study First Posted: 2013-12-25
• Last Update Posted: 2013-12-25

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 223

Inclusion Criteria

Age >18 Not pregnant Smear negative

Exclusion Criteria

Chronic pelvic pain Pregnancy Uterine anomaly Fibroid Acute cervicitis Pelvic inflammatory disease Cervical stenosis

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
saline spray application	Placebo	Placebo group
lidocaine spray application	Lidocaine Spray	2 puff lidocaine spray applicated before IUD insertion

Primary Outcome Measures

Name	Time	Method
Pain	3 months	10 cm VAS scale

Trial Locations

Locations (1)

Kayseri Education and Research Hospital of Medicine; 🇹🇷 Kayseri, Turkey